EtiraRX, Inc.
Biotechnology · DALLAS, TX
BiotechnologySEC Form D
EtiraRX, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 14, 2026, reporting $2,277,533 raised toward a $3,000,003 offering.
Incorporated in Delaware and based in DALLAS, TX, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that EtiraRX, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Russell HaywardExecutive Officer · Director
- Ganesh RajExecutive Officer · Director
- Justin StebbingDirector
- Annalisa JenkinsDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised